Fabio Vieira Teixeira

13PUBLICATIONS
72CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological methodsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 25, 2026
REGIONAL AND MULTIFACTORIAL PATTERNS OF INFLAMMATORY BOWEL DISEASE IN BRAZIL: A SYSTEMATIC ANALYSIS OF HOT SPOTS IN WESTERN SÃO PAULO AND PARANÁ.

|Mar 19, 2025
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro

|Jul 24, 2024
ARE WE READY FOR MULTIPLE SWITCHES BETWEEN REFERENCE PRODUCTS AND BIOSIMILARS?

Fabio Vieira Teixeira, Laurent Peyrin-Biroulet, Silvio Danese

|Apr 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo

|Feb 13, 2023
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.

Ramir Luan Perin, Daniela Oliveira Magro, Adriana Ribas Andrade

|Jun 01, 2022
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).

Ligia Yukie Sassaki, Daniela Oliveira Magro, Rogerio Saad-Hossne

Pageof 3

Frequent Collaborators

6 joint publications

Natália Sousa Freitas Queiroz

5 joint publications

Paulo Gustavo Kotze

5 joint publications

Aderson Omc Damião

5 joint publications

Rogerio Serafim Parra